‘Brainless’ US MFN Policy Could Drive Pharma Investment To Europe

 
• By Francesca Bruce
  
Plans for a most favored nations drug pricing policy are creating an unpredictable environment, which may drive investment to Europe. (Shutterstock)

More from Pricing Debate

More from Market Access